| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 7.631 | 7.536 | 10.863 | 3.559 | 6.156 | 4.212 |
| Total Income - EUR | - | - | - | 0 | 7.631 | 7.536 | 10.863 | 3.559 | 6.156 | 4.212 |
| Total Expenses - EUR | - | - | - | 1.231 | 6.564 | 6.613 | 10.376 | 4.002 | 9.314 | 9.543 |
| Gross Profit/Loss - EUR | - | - | - | -1.231 | 1.067 | 922 | 487 | -444 | -3.158 | -5.331 |
| Net Profit/Loss - EUR | - | - | - | -1.231 | 937 | 771 | 232 | -551 | -3.158 | -5.331 |
| Employees | - | - | - | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Total Bio-Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 92 | 1.860 | 11.821 | 11.473 | 11.508 | 14.506 | 12.833 |
| Current Assets | - | - | - | 212 | 416 | 2.472 | 8.375 | 8.523 | 7.964 | 7.161 |
| Inventories | - | - | - | 0 | 0 | 2.261 | 6.770 | 6.791 | 6.770 | 6.732 |
| Receivables | - | - | - | 0 | 0 | 1 | 0 | 51 | 0 | 0 |
| Cash | - | - | - | 212 | 416 | 210 | 1.606 | 1.682 | 1.194 | 429 |
| Shareholders Funds | - | - | - | -1.188 | -228 | 547 | 767 | 219 | -2.940 | -8.255 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 1.492 | 2.504 | 13.745 | 19.081 | 19.813 | 25.410 | 28.249 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Total Bio-Med S.r.l.